Russell Investments Group
FHTX icon

Russell Investments Group’s Foghorn Therapeutics FHTX Stock Holding History

Russell Investments Group’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Sell
2,898
-3,040
-51% -$16.7K ﹤0.01% 3709
2025
Q4 		$32.1K Buy
5,938
+396
+7% +$1.79K ﹤0.01% 3467
2025
Q3 		$27.1K Buy
5,542
+5,502
+13,755% +$29.2K ﹤0.01% 3505
2025
Q2 		$188 Sell
40
-1,331
-97% -$5.56K ﹤0.01% 3791
2025
Q1 		$5K Sell
1,371
-106
-7% -$483 ﹤0.01% 3361
2024
Q4 		$6.97K Hold
1,477
– – ﹤0.01% 3215
2024
Q3 		$13.8K Buy
+1,477
New +$10.7K ﹤0.01% 3029
2024
Q1 		– Sell
-100
Closed -$645 – 3328
2023
Q4 		$645 Buy
+100
New +$431 ﹤0.01% 3099
2023
Q2 		– Sell
-30,017
Closed -$186K – 3475
2023
Q1 		$186K Buy
+30,017
New +$196K ﹤0.01% 2488

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Russell Investments Group's FHTX Position: Q1 2026 in Review

Russell Investments Group reduced its Foghorn Therapeutics (FHTX) stake by 51% in Q1 2026, selling an estimated $16.7K and leaving 2,898 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3709.

Russell Investments Group first reported a position in FHTX in Q1 2023 and has held it in 9 quarters since. The position peaked at $186K in Q1 2023. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Russell Investments Group held 2,898 shares of Foghorn Therapeutics worth $13.9K as of Q1 2026.
  • Russell Investments Group sold 3,040 Foghorn Therapeutics shares in Q1 2026, an estimated $16.7K.
  • Foghorn Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3709 holding.
  • Russell Investments Group first reported a position in Foghorn Therapeutics in Q1 2023 and has held it in 9 quarters since.
  • Russell Investments Group's Foghorn Therapeutics position peaked at $186K in Q1 2023.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.